Syndax Pharmaceuticals OverviewSyndax Pharmaceuticals Net Income
Profitability analysis for SNDX.
Quarterly Net Income
-$42.67M
↑ 49.71% YoY
As of Mar 2026
Annual Net Income (TTM)
-$243.25M
↑ 26.56% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...